Big pharma turns to AI to speed drug discovery, GSK signs deal
Reuters: Health News
LONDON (Reuters) - The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday.
ABC News: Health
Utah health authorities say they are investigating an outbreak of E.coli after two children died in a city on the Arizona border that's home to a polygamist Mormon sect
No comments:
Post a Comment